Cetuximab and irinotecan

DRUG2 trials

Sponsors

Kobe University Hospital, Sun Yat-sen University

Conditions

Metastatic Colorectal CancerRecurrent or metastatic colorectal cancer

Phase 2

Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy

RecruitingNCT05962502

Sun Yat-sen UniversityMetastatic Colorectal Cancer

Start: 2023-08-24End: 2026-12-30Target: 54Updated: 2023-08-31

Unknown Phase

Cetuximab biomarker study

Active, not recruitingJPRN-UMIN000002165

Kobe University HospitalRecurrent or metastatic colorectal cancer

Start: 2009-10-01Target: 30Updated: 2026-06-29